Keith S. Lanier

3.5k total citations
15 papers, 1.1k citations indexed

About

Keith S. Lanier is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Keith S. Lanier has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Surgery. Recurrent topics in Keith S. Lanier's work include Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Keith S. Lanier is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Keith S. Lanier collaborates with scholars based in United States. Keith S. Lanier's co-authors include Bella M. DePaulo, Tracy C. Davis, Robert Chapman, Shaker R. Dakhil, James D. Bearden, Philip R. Greipp, Jason McCoy, Jeana Cromer, Sydney E. Salmon and Brian G.M. Durie and has published in prestigious journals such as Journal of Personality and Social Psychology, Journal of Clinical Oncology and Cancer.

In The Last Decade

Keith S. Lanier

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith S. Lanier United States 10 567 456 288 144 129 15 1.1k
Georgia Schilling Germany 18 472 0.8× 610 1.3× 443 1.5× 173 1.2× 20 0.2× 62 1.3k
June A. Peters United States 21 435 0.8× 138 0.3× 586 2.0× 37 0.3× 36 0.3× 66 2.2k
Jennifer T. Loud United States 19 430 0.8× 101 0.2× 450 1.6× 31 0.2× 24 0.2× 45 1.6k
Jack Lindh Sweden 17 395 0.7× 82 0.2× 160 0.6× 13 0.1× 318 2.5× 51 1.1k
Laurie Ford United States 23 320 0.6× 457 1.0× 377 1.3× 7 0.0× 55 0.4× 66 1.2k
Laura Evelia Torres Velázquez Mexico 13 872 1.5× 223 0.5× 502 1.7× 11 0.1× 27 0.2× 50 1.6k
Craig A. Bunnell United States 21 2.2k 3.8× 102 0.2× 289 1.0× 150 1.0× 71 0.6× 50 2.7k
Robert Rohrberg Germany 14 486 0.9× 230 0.5× 108 0.4× 22 0.2× 45 0.3× 27 1.1k
Anne‐Marie Martin United States 22 780 1.4× 54 0.1× 798 2.8× 21 0.1× 21 0.2× 61 1.9k
Eva Tomiak Canada 22 848 1.5× 41 0.1× 293 1.0× 69 0.5× 11 0.1× 59 1.6k

Countries citing papers authored by Keith S. Lanier

Since Specialization
Citations

This map shows the geographic impact of Keith S. Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Lanier more than expected).

Fields of papers citing papers by Keith S. Lanier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Lanier. The network helps show where Keith S. Lanier may publish in the future.

Co-authorship network of co-authors of Keith S. Lanier

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Lanier. A scholar is included among the top collaborators of Keith S. Lanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Lanier. Keith S. Lanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zaren, Howard A., Suresh Nair, Ronald S. Go, et al.. (2013). Early-Phase Clinical Trials In The Community: Results From the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment. Journal of Oncology Practice. 9(2). e55–e61. 10 indexed citations
2.
Schott, Anne F., William E. Barlow, Kathy S. Albain, et al.. (2012). Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430. The Oncologist. 17(2). 179–187. 8 indexed citations
3.
4.
Barton, Debra L., Edward J. Wos, Rui Qin, et al.. (2010). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive Care in Cancer. 19(6). 833–841. 195 indexed citations
5.
Lew, Danika L., Kathy S. Albain, Helen K. Chew, et al.. (2010). Simple oral therapy with capecitabine (CAPE) and cyclophosphamide (CPA) for metastatic breast cancer (MBC).. Journal of Clinical Oncology. 28(15_suppl). 1006–1006. 4 indexed citations
6.
Fowler, Cedar, Keith Hansen, Lisa Hansen, et al.. (2009). Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplantation. 43(12). 909–917. 57 indexed citations
7.
Barton, Debra L., Edward J. Wos, Rui Qin, et al.. (2009). A randomized controlled trial evaluating a topical treatment for chemotherapy-induced neuropathy: NCCTG trial N06CA. Journal of Clinical Oncology. 27(15_suppl). 9531–9531. 4 indexed citations
8.
Land, Stephanie R., Jacek A Kopec, Reena S. Cecchini, et al.. (2007). Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07. Journal of Clinical Oncology. 25(16). 2205–2211. 184 indexed citations
9.
Barlogie, Bart, Robert A. Kyle, Kenneth C. Anderson, et al.. (2006). Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321. Journal of Clinical Oncology. 24(6). 929–936. 339 indexed citations
10.
Zalupski, Mark M., Cathryn Rankin, James R. Ryan, et al.. (2004). Adjuvant therapy of osteosarcoma—A Phase II trial. Cancer. 100(4). 818–825. 49 indexed citations
11.
Velasquez, William S., Danika L. Lew, Thomas M. Grogan, et al.. (2003). Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501. Journal of Clinical Oncology. 21(10). 1996–2003. 43 indexed citations
12.
Lau, Dennis H., John J. Crowley, David R. Gandara, et al.. (1998). Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.. Journal of Clinical Oncology. 16(9). 3078–3081. 45 indexed citations
13.
Strong, Stanley R., et al.. (1988). The dynamic relations among interpersonal behaviors: A test of complementarity and anticomplementarity.. Journal of Personality and Social Psychology. 54(5). 798–810. 51 indexed citations
14.
DePaulo, Bella M., Keith S. Lanier, & Tracy C. Davis. (1983). Detecting the deceit of the motivated liar.. Journal of Personality and Social Psychology. 45(5). 1096–1103. 111 indexed citations
15.
DePaulo, Bella M., Keith S. Lanier, & Tracy C. Davis. (1983). Detecting the deceit of the motivated liar.. Journal of Personality and Social Psychology. 45(5). 1096–1103. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia Schilling Breakdown of academic impact, for papers by June A. Peters Breakdown of academic impact, for papers by Jennifer T. Loud Breakdown of academic impact, for papers by Jack Lindh Breakdown of academic impact, for papers by Laurie Ford Breakdown of academic impact, for papers by Laura Evelia Torres Velázquez Breakdown of academic impact, for papers by Craig A. Bunnell Breakdown of academic impact, for papers by Robert Rohrberg Breakdown of academic impact, for papers by Anne‐Marie Martin Breakdown of academic impact, for papers by Eva Tomiak
Rankless by CCL
2026